Apronal (CAS No 528-92-7) is a compound used in biomedical research primarily within the category of sedative-hypnotic agents Originating from modifications of barbiturates it acts by targeting the central nervous system specifically enhancing GABAergic activity which leads to its sedative effects In vitro Apronal shows activity within the nanomolar to low micromolar range indicating its potency in cellular assays Typical applications include investigations using various cell models to explore its pharmacological effects as well as in animal studies aimed at understanding its mechanism in vivo Additionally Apronal is often utilized in drug screening to assess its interactions with other compounds aiding in the development of new therapeutic agents Experimental concentrations typically depend on the specific research design ensuring flexibility in diverse scientific inquiries